Clobevate Related Clinical Trials
A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam [Completed]
Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis [Completed]
Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis [Completed]
Maintenance Effect of Clobex Shampoo on Subjects With Moderate to Severe Scalp Psoriasis [Completed]
Evaluate Safety/Efficacy of Two Treatment Regimens for Vecticalâ„¢ Ointment & Clobex® Spray for Moderate Plaque Psoriasis [Not yet recruiting]
Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis [Recruiting]
Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus [Recruiting]
Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp [Recruiting]
Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis [Completed]
Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis [Not yet recruiting]
Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-Propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound [Recruiting]
Clobetasol Propionate 0.05% Shampoo in Association With Antifungal Shampoo in Scalp Seborrheic Dermatitis [Recruiting]
Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus [Recruiting]
Hydroxychloroquine vs. Clobetasol Rinse to Treat Oral Lichen Planus [Completed]
Subject Preference for Scalp Psoriasis Treatment [Active, not recruiting]
Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis [Recruiting]
Optimization of UV Radiation Therapy in Psoriasis [Recruiting]
Phase I Study of Topical CRx-191 in Normal Healthy Volunteers [Completed]
Efficacy and Safety of TF002 in Cutaneous Mastocytosis [Completed]
|
